Summit Rock Advisors, LP
- SEC CIK
- 0001540951
- Latest filing
- Aug 4, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 8
- +3 vs. Q3 2021
- Portfolio value
- $167.4M
- −$1.16M (−0.7%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DYNDyne Therapeutics, Inc. | COM | 34,887 | $415.0K | 0.2% | +34,887 | New | History |
| MNDYmonday.com Ltd. | SHS | 1,676 | $517.0K | 0.3% | +1,676 | New | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 33,125 | $558.0K | 0.3% | +33,125 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 34,100 | $671.0K | 0.4% | 00.0% | Unchanged | History |
| CLOVClover Health Investments, Corp. | COM CL A | 210,639 | $784.0K | 0.5% | 00.0% | Unchanged | History |
| iShares Tr464287630 | RUS 2000 VAL ETF | 283,472 | $47.1M | 28.1% | −130,580−31.5% | Reduced | – |
| iShares Core S&P US Value ETF464287663 | ETF | 740,195 | $56.5M | 33.8% | 00.0% | Unchanged | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 413,962 | $60.9M | 36.4% | +65,885+18.9% | Added | – |